Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity
Kate Poropatich, … , Sandeep Samant, Bin Zhang
Kate Poropatich, … , Sandeep Samant, Bin Zhang
Published March 17, 2020
Citation Information: J Clin Invest. 2020;130(7):3528-3542. https://doi.org/10.1172/JCI131992.
View: Text | PDF
Research Article Immunology Oncology Article has an altmetric score of 4

OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity

  • Text
  • PDF
Abstract

Plasmacytoid DCs (pDCs), the major producers of type I interferon, are principally recognized as key mediators of antiviral immunity. However, their role in tumor immunity is less clear. Depending on the context, pDCs can promote or suppress antitumor immune responses. In this study, we identified a naturally occurring pDC subset expressing high levels of OX40 (OX40+ pDC) enriched in the tumor microenvironment (TME) of head and neck squamous cell carcinoma. OX40+ pDCs were distinguished by a distinct immunostimulatory phenotype, cytolytic function, and ability to synergize with conventional DCs (cDCs) in generating potent tumor antigen–specific CD8+ T cell responses. Transcriptomically, we found that they selectively utilized EIF2 signaling and oxidative phosphorylation pathways. Moreover, depletion of pDCs in the murine OX40+ pDC–rich tumor model accelerated tumor growth. Collectively, we present evidence of a pDC subset in the TME that favors antitumor immunity.

Authors

Kate Poropatich, Donye Dominguez, Wen-Ching Chan, Jorge Andrade, Yuanyuan Zha, Brian Wray, Jason Miska, Lei Qin, Lisa Cole, Sydney Coates, Urjeet Patel, Sandeep Samant, Bin Zhang

×

Figure 5

OX40+ pDCs harbor a unique transcriptome.

Options: View larger image (or click on image) Download as PowerPoint
OX40+ pDCs harbor a unique transcriptome.
(A–F and I) Bulk RNA sequencin...
(A–F and I) Bulk RNA sequencing was performed on cell-sorted pDCs from HNSCC patients (n = 7) (Supplemental Table 2). DEGs were determined using the criterion of fold changes (FC) greater than or equal to 1.5 (see Methods). (A) Principal component analysis showing the clustering of transcriptional profiles of TME and non-TME pDCs (top), including pDCs from HPV+ patients (bottom). (B) Top: log2 expression of TNF-receptor genes upregulated in the TME of pDC samples. Bottom: expression of TNFSF4 in the TME versus non-TME pDCs. (C) Volcano plot of gene expression in OX40+ pDCs relative to their expression in OX40lo/– pDCs (up- and downregulated in OX40+ pDCs colored as magenta and orange, respectively) against the FDR. (D) Top pathways (–log[P value] > 2.0) generated from IPA enriched in OX40+ and OX40lo/– pDCs, respectively. Corresponding ratios for each enriched pathway are measured on the second y axis. Full pathway title: Nitrous Oxide and Reactive Oxygen Species Production in Macrophages. (E) Expression of genes involved in MHC I antigen presentation enriched in HPV+ HNSCC OX40+ pDCs. (F) Heat map reporting relative expression of 183 DEGs in OX40+/OX40lo/– pDCs. Gene pathway clusters are demarcated by boxes. (G) Functional correlative data for cluster II (OXPHOS) in OX40+ pDCs. Left: Mitochondrial mass measurements in pDC subsets from the TME were calculated using Imaris (see Methods). Original magnification, ×100. Scale bar: 5 μm. n = 3; 3 experimental repeats. Right: Real-time analysis of OXPHOS (oxygen consumption ratios measured by Seahorse assay) in sorted pDCs from the TME. n = 2; 2 experimental repeats. (H) Functional correlative data for cluster III (detoxification of ROS): total ROS volumes and ROS colocalized to mitochondria volumes in pDCs from the TME. n = 2; 2 patient experimental repeats. (I) Expression of genes involved in cluster VI (type I IFN signaling) upregulated in OX40+ pDCs. Unpaired Student’s t test (B and F–I) and right-tailed Fisher’s exact test (E). *P < 0.05; **P < 0.01, ***P < 0.001; NS, not significant. Error bars represent mean ± SEM of technical duplicates. Middle line of box-and-whisker plot indicates the median, box limits indicate the first and third quartiles, and whiskers indicate “extreme” for all data points. Z scores and genes for IPA in Source Data 1.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 6 X users
59 readers on Mendeley
See more details